Multivesicular Liposome (Depofoam) in Human Diseases

Area of Science:

• Drug delivery systems
• Nanotechnology
• Pharmaceutical sciences

Background:

• Drug development focuses on enhancing drug loading and prolonging effects.
• Multivesicular liposomes (DepoFoam) are a nanotechnology for sustained drug release.
• Reduced administration frequency is crucial for prolonged treatments.

Purpose of the Study:

• To review the literature on DepoFoam structure, preparation, and pharmacokinetics.
• To investigate approved DepoFoam formulations.
• To examine preclinical studies utilizing DepoFoam nanotechnology.

Main Methods:

• Literature review of DepoFoam.
• Analysis of approved DepoFoam drug formulations.
• Evaluation of preclinical DepoFoam studies.

Main Results:

• DepoFoam enables sustained drug concentration and reduced dosing frequency.
• Approved DepoFoam drugs are used for neurological diseases and post-surgical pain.
• Preclinical DepoFoam studies show potential in cancer treatment by improving bioavailability, stability, and targeted delivery, while minimizing side effects.

Conclusions:

• DepoFoam is a versatile nanotechnology for advanced drug delivery.
• It offers significant advantages in therapeutic efficacy and patient compliance.
• Further research and development in DepoFoam hold promise for various medical applications.